Both in Pharmaceuticals
Monopar Therapeutics vs Aquestive Therapeutics
Over the past year MNPR returned −21.1% and AQST returned −41.9%; their daily moves had a correlation of 0.22.
MNPR −21.1% AQST −41.9%Growth of $1, one year, split-adjusted
| Metric | MNPR | AQST |
|---|---|---|
| Price | $66.28 | $3.77 |
| Market cap | $444.9M | $473.2M |
| Today | −5.75% | −3.08% |
| 1 month | −15.0% | −17.1% |
| 6 months | +21.3% | −10.7% |
| Year to date | +1.5% | −41.6% |
| 1 year | −22.6% | −43.4% |
| Revenue growth (YoY) | — | +38.1% |
| Gross margin | — | 70.9% |
| Net margin | — | −165.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.7× |
| Net cash | $134.3M | $47.8M |
| Dividend yield | — | — |
| Volatility (60d) | 50.2% | 56.8% |
| Short % of float | 23.3% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).